SE7406677L - 1-ÿbeta-(4-aminokarbonylfenoxi)etylaminoÿ-3-(tiazol-2-oxi)-propanol, derivat derav och sett att framstella sadana foreningar. - Google Patents

1-ÿbeta-(4-aminokarbonylfenoxi)etylaminoÿ-3-(tiazol-2-oxi)-propanol, derivat derav och sett att framstella sadana foreningar.

Info

Publication number
SE7406677L
SE7406677L SE7406677A SE7406677A SE7406677L SE 7406677 L SE7406677 L SE 7406677L SE 7406677 A SE7406677 A SE 7406677A SE 7406677 A SE7406677 A SE 7406677A SE 7406677 L SE7406677 L SE 7406677L
Authority
SE
Sweden
Prior art keywords
ÿbeta
ethylaminoÿ
aminocarbonylphenoxy
tiazole
derivated
Prior art date
Application number
SE7406677A
Other languages
English (en)
Swedish (sv)
Inventor
J A Edwards
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of SE7406677L publication Critical patent/SE7406677L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02Lithium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7406677A 1974-03-14 1974-05-20 1-ÿbeta-(4-aminokarbonylfenoxi)etylaminoÿ-3-(tiazol-2-oxi)-propanol, derivat derav och sett att framstella sadana foreningar. SE7406677L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US451194A US3896139A (en) 1974-03-14 1974-03-14 Process for preparing 3-(4-or-5-azidocarbonylthiazol-2-oxy)-propanediol-1,2-acetonides
US451195A US3897442A (en) 1974-03-14 1974-03-14 Thiazole cardiovascular agents

Publications (1)

Publication Number Publication Date
SE7406677L true SE7406677L (sv) 1975-09-15

Family

ID=27036271

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7406677A SE7406677L (sv) 1974-03-14 1974-05-20 1-ÿbeta-(4-aminokarbonylfenoxi)etylaminoÿ-3-(tiazol-2-oxi)-propanol, derivat derav och sett att framstella sadana foreningar.

Country Status (9)

Country Link
US (2) US3897442A (US07655688-20100202-C00086.png)
JP (2) JPS50123673A (US07655688-20100202-C00086.png)
AU (1) AU6693674A (US07655688-20100202-C00086.png)
BE (2) BE812689R (US07655688-20100202-C00086.png)
DE (2) DE2414038A1 (US07655688-20100202-C00086.png)
FR (2) FR2278336A2 (US07655688-20100202-C00086.png)
GB (2) GB1461173A (US07655688-20100202-C00086.png)
NL (2) NL7403855A (US07655688-20100202-C00086.png)
SE (1) SE7406677L (US07655688-20100202-C00086.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064259A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
CH674204A5 (US07655688-20100202-C00086.png) * 1986-06-11 1990-05-15 Nippon Shinyaku Co Ltd
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2003270562B2 (en) * 2002-09-12 2010-09-16 Diakron Pharmaceuticals, Inc. Calcium channel blockers
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1047927A (en) * 1964-03-09 1966-11-09 Ici Ltd Alkanolamine derivatives
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
DE1795106B2 (de) * 1968-08-10 1976-04-29 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2- brom- oder chlor-5-nitrothiazol

Also Published As

Publication number Publication date
AU6776674A (en) 1975-10-16
NL7403855A (nl) 1975-09-16
AU6693674A (en) 1975-09-25
FR2258181A1 (US07655688-20100202-C00086.png) 1975-08-18
GB1461173A (en) 1977-01-13
US3896139A (en) 1975-07-22
GB1455945A (en) 1976-11-17
NL7405599A (nl) 1975-09-16
FR2278336A2 (fr) 1976-02-13
BE812689R (fr) 1974-09-23
DE2414038A1 (de) 1975-10-09
US3897442A (en) 1975-07-29
JPS50123671A (US07655688-20100202-C00086.png) 1975-09-29
JPS50123673A (US07655688-20100202-C00086.png) 1975-09-29
DE2416016A1 (de) 1975-09-25
BE815388A (fr) 1974-11-22

Similar Documents

Publication Publication Date Title
NO142048C (no) Ventilasjonsapparat.
NO144263C (no) Fremgangsmaate for fremstilling av etylen- henholdsvis propylen-karbonat.
SE7508405L (sv) Forfarande for framstellning av polyfenyloxid.
SE7508406L (sv) Forfarande for framstellning av polyfenylenoxid.
SE428679B (sv) Sett for koronareaktioner
SE7406677L (sv) 1-ÿbeta-(4-aminokarbonylfenoxi)etylaminoÿ-3-(tiazol-2-oxi)-propanol, derivat derav och sett att framstella sadana foreningar.
NO143574B (no) Fremgangsmaate for fremstilling av aziner.
SE7508908L (sv) Sett att framstella kardiotona steroidforeningar och glykosidderivat derav.
SE7509126L (sv) Sett att framstella 1-substituerade 2-metyl-tetrahydropyrimidiner.
FI51888C (fi) Kiertoilmauuni.
SE7506379L (sv) N-alken-(1)-yl(1)-monohalogenacetamider och sett att framstella sadana.
NO140875C (no) Hemodialyseapparat.
SE7502682L (sv) Anordning for settning av plantor o.dyl.
NO144854C (no) Fremgangsmaate for fremstilling av mikroorganismer.
NO146714C (no) Fremgangsmaate for fremstilling av saapestykker.
SE7508858L (sv) Sett att framstella basiska derivat av 1-aryl-2-oxo-2,4,5,7,7a-hexahydroindoler.
SE7613545L (sv) Sett att framstella difluormetyl-1,2,2-triflnoretyleter
SE7504605L (sv) Forfarande for utvinning av alkalimetallazid.
NL7603623A (nl) Massacopolymerisatieproces.
SE7506573L (sv) Sett att framstella nya derivat av dibenso-(b,e)-tiepin och salter derav.
NO145585C (no) Glassvegg.
SE385302B (sv) Sett att framstella 5-aminometyl-6-karbetoxi-oxazino(5',6'e)indolderivat
SE394815B (sv) Sett att framstella vissa angivna (3-benso-1,2,4-triazinyl-dioxid-1,4)-karbamider
SE407410B (sv) Sett att framstella 3-oxo-17beta-n-amyloxi-ostra-4,9,11-trien
DK136979B (da) Fremgangsmåde til fremstilling af dibenzofuran.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7406677-0

Effective date: 19761230